Neuro-Innovators, LLC. Accelerating Neuroplastic Medicine™ Neuro-Innovators (NIV) is a clinical stage drug company engineering drugs to accelerate Brain Neuroplasticity (i.e., the capacity of the brain to rebuild, rewire, and recover) for patients suffering with brain injuries and diseases. We believe that neuroplasticity –the remodeling of the brain after impairments from injury or disease– can help alter the course of brain impairments related to dementia, depression, movement disorders, immune-system attacks, psychiatric illness, and cognition deficits. These ailments are a heavy burden on individuals, family, communities, nations, and the globe. Our first drug NIV-001 is engineered to address the unmet need of 7 million US stroke patients many with chronic motor deficits ~$50 billion problem. NIV-001 could be a game changer for patients and society. NIV expects to be in human trials within 12 months and selling NIV-001 commercially within 5 years. Come help us and let us know if you would like to learn more. h.schroeder@niv-neuro.com